ClinicalTrials.Veeva

Menu

Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer (NSCLC)

Capital Medical University logo

Capital Medical University

Status

Unknown

Conditions

Non-small Cell Lung Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT02202655
13501185982

Details and patient eligibility

About

The purpose of this study is to investigate the changes of lymphocyte subsets in chemotherapy course of patients with non-small cell lung cancer

Full description

patients with primary non-small cell lung cancer who received first chemotherapy in Beijing Chaoyang Hospital affiliated to Capital Medical University were collected, and the percentage of lymphocyte subsets at 9 time points before, during, and after chemotherapy was detected by flow cytometry method.We will investigate the changes of patients' lymphocyte subsets in chemotherapy courses. The correlation of the percentage of lymphocyte subsets and age, gender, pathological type, clinical stage, surgery or not, clinical efficacy assessment will be further analyzed.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Each Period Non-small Cell Lung Cancer, Which Was Confirmed by Histopathology. patients has only lung cancer .
  • Functional Status Score (PS) ≧ 70.
  • The first time for chemotherapy .
  • A Written Informed Consent.

Exclusion criteria

  • Merging other tumors.
  • HAve autoimmune diseases.
  • AIDS

Trial contacts and locations

1

Loading...

Central trial contact

qian wang, master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems